{
    "code": "06024534",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06024534",
    "time": "2019-08-16 03:07:08",
    "許可證字號": "衛署醫器輸字第024534號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/02\/06",
    "發證日期": "102\/02\/06",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602453403",
    "中文品名": "希摩西爾狼瘡性抗凝血因子品管血漿",
    "英文品名": "HemosIL LA Positive Control and HemosIL LA Negative Control",
    "效能": "在IL血液凝固儀器【ACL TOP系列,ACL ELITE\/ELITE PRO\/8\/9\/10000,ACL Futura\/ACL Advance,ACL Classic(100-7000)】上作為狼瘡性抗凝固因子分析(dRVVT  Screen\/dRVVT Confirm, LAC Screen\/LAC Confirm, Silica Clotting time)的LA品質管制",
    "醫器規格": "0020012500,0020012600以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "主成分略述": "",
    "主製造廠": {
        "申請商名稱": "640110B420  台灣沃芬有限公司",
        "申請商地址": "臺北市內湖區堤頂大道二段501號4樓",
        "主製造廠": "",
        "製造廠名稱": "MUS2610000  INSTRUMENTATION LABORATORY CO.",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060245340002___20130329.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024534&Seq=001&Type=9"
        },
        {
            "title": "060245340001___20130329.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024534&Seq=001&Type=8"
        }
    ]
}